

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.14809892 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.74647636 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62122395 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.62122395 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27848256 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.27848256 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.06818413 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.86201497 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.43615048 |
| 10 | oxidative demethylation (GO:0070989) | 6.31564371 |
| 11 | phenylpropanoid metabolic process (GO:0009698) | 6.26946186 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.18612866 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.18612866 |
| 14 | tryptophan catabolic process (GO:0006569) | 6.18612866 |
| 15 | drug metabolic process (GO:0017144) | 6.16714481 |
| 16 | kynurenine metabolic process (GO:0070189) | 6.06966019 |
| 17 | bile acid biosynthetic process (GO:0006699) | 6.00977129 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.81977898 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.78569740 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.69407086 |
| 21 | urea metabolic process (GO:0019627) | 5.67730157 |
| 22 | urea cycle (GO:0000050) | 5.67730157 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.66157166 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.64880781 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.46079707 |
| 26 | protein carboxylation (GO:0018214) | 5.43145221 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43145221 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.34170107 |
| 29 | cysteine metabolic process (GO:0006534) | 5.32203793 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.30167554 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.28445825 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.21903406 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.14371744 |
| 34 | alkaloid metabolic process (GO:0009820) | 5.04823145 |
| 35 | * bile acid metabolic process (GO:0008206) | 4.98624973 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.98249756 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.92901445 |
| 38 | regulation of complement activation (GO:0030449) | 4.92885872 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.92576833 |
| 40 | regulation of plasminogen activation (GO:0010755) | 4.89425968 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.86018128 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85290310 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.83950977 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81514930 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.81514930 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.81514930 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.78387869 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.78387869 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.73462203 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.66087135 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.65222643 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.65222643 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.63121404 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.63121404 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.62786102 |
| 56 | phospholipid efflux (GO:0033700) | 4.61553748 |
| 57 | hormone catabolic process (GO:0042447) | 4.61082003 |
| 58 | lysine catabolic process (GO:0006554) | 4.58121341 |
| 59 | lysine metabolic process (GO:0006553) | 4.58121341 |
| 60 | ethanol metabolic process (GO:0006067) | 4.57097398 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.52749744 |
| 62 | S-adenosylmethionine metabolic process (GO:0046500) | 4.48347932 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 4.46271587 |
| 64 | glycine metabolic process (GO:0006544) | 4.44107828 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.42164092 |
| 66 | coenzyme catabolic process (GO:0009109) | 4.39107939 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.38290201 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.38053969 |
| 69 | negative regulation of wound healing (GO:0061045) | 4.36398569 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.35707521 |
| 71 | steroid catabolic process (GO:0006706) | 4.34344866 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.29798440 |
| 73 | amine catabolic process (GO:0009310) | 4.29798440 |
| 74 | cellular glucuronidation (GO:0052695) | 4.29193252 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.28336876 |
| 76 | cholesterol efflux (GO:0033344) | 4.26241442 |
| 77 | glutamate metabolic process (GO:0006536) | 4.24117349 |
| 78 | heme transport (GO:0015886) | 4.21120389 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.17568957 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.14685570 |
| 81 | ethanol oxidation (GO:0006069) | 4.13677728 |
| 82 | * bile acid and bile salt transport (GO:0015721) | 4.12735497 |
| 83 | regulation of humoral immune response (GO:0002920) | 4.05453488 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.04365149 |
| 85 | arginine metabolic process (GO:0006525) | 4.04333612 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.04265737 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03439786 |
| 88 | fibrinolysis (GO:0042730) | 4.03256270 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 4.01346117 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.00874475 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 4.00818882 |
| 92 | flavonoid metabolic process (GO:0009812) | 3.98136540 |
| 93 | positive regulation of hemostasis (GO:1900048) | 3.97974127 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.97974127 |
| 95 | negative regulation of complement activation (GO:0045916) | 3.96949482 |
| 96 | acute-phase response (GO:0006953) | 3.96717958 |
| 97 | drug catabolic process (GO:0042737) | 3.95984135 |
| 98 | ketone body metabolic process (GO:1902224) | 3.92093167 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89491088 |
| 100 | regulation of lipoprotein particle clearance (GO:0010984) | 3.88837558 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82217669 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82217669 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.80937896 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.80937896 |
| 105 | cofactor catabolic process (GO:0051187) | 3.80700941 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.78570103 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.78360575 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.76949408 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.76698741 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.75365954 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75252588 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.75184031 |
| 113 | organic acid catabolic process (GO:0016054) | 3.75184031 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73225230 |
| 115 | complement activation (GO:0006956) | 3.72475941 |
| 116 | protein activation cascade (GO:0072376) | 3.72425273 |
| 117 | sterol homeostasis (GO:0055092) | 3.70454664 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.70084513 |
| 119 | positive regulation of coagulation (GO:0050820) | 3.69825663 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.68788372 |
| 121 | drug transmembrane transport (GO:0006855) | 3.68265317 |
| 122 | xenobiotic metabolic process (GO:0006805) | 3.68179062 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 3.65467449 |
| 124 | cytolysis (GO:0019835) | 3.63804535 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.61580499 |
| 126 | protein-lipid complex assembly (GO:0065005) | 3.59786537 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.57900753 |
| 128 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54807252 |
| 129 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.47551261 |
| 130 | daunorubicin metabolic process (GO:0044597) | 3.44276322 |
| 131 | polyketide metabolic process (GO:0030638) | 3.44276322 |
| 132 | doxorubicin metabolic process (GO:0044598) | 3.44276322 |
| 133 | intestinal cholesterol absorption (GO:0030299) | 3.44084224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42933963 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22557821 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03044638 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51813251 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31727271 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05011248 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83502227 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05150440 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89383322 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07828978 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0115066 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97211441 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95277059 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59437480 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58846589 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53105184 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43422647 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39834508 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27100645 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20074776 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17853942 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17518336 |
| 23 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15356541 |
| 24 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.14064156 |
| 25 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.08405655 |
| 26 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05347204 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04966749 |
| 28 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03318444 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02962987 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02275114 |
| 31 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02140415 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99144325 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98147190 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96224591 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95856976 |
| 36 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94539474 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91856952 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90903124 |
| 39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.89897385 |
| 40 | NFYA_21822215_ChIP-Seq_K562_Human | 0.89192015 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87198606 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84976084 |
| 43 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84879271 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84195410 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83803099 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83235247 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82016727 |
| 48 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.81443645 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80377789 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80162515 |
| 51 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79195465 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78778289 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78143137 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77960640 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77458996 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77011022 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76668821 |
| 58 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.75379864 |
| 59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.74672667 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74328847 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.74300262 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74032874 |
| 63 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73614917 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72037187 |
| 65 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.71190853 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70958767 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70658983 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70332571 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69960457 |
| 70 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69704843 |
| 71 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.69576741 |
| 72 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.68658970 |
| 73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67021056 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66795338 |
| 75 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.66740671 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66638451 |
| 77 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.65740301 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65562433 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.65496919 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65349468 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65349468 |
| 82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.65231734 |
| 83 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.64417829 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64394053 |
| 85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64115740 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.64111464 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.64074575 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.63552887 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.63441070 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.63441070 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63425217 |
| 92 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63253400 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.63207697 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62799544 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.62746033 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62394907 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61046529 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.59810449 |
| 99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.58842028 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.58842028 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58801213 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.57842171 |
| 103 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54455698 |
| 104 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53201304 |
| 105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53187886 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53092706 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52897211 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52131957 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51909134 |
| 110 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51309594 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51004600 |
| 112 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50365678 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49775016 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49435797 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.49350553 |
| 116 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48803912 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48483393 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48476609 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46498890 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46239764 |
| 121 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44753241 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44319954 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43122525 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42630349 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42267588 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42078878 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41498276 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41413604 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41081260 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41031198 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40287236 |
| 132 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40192824 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39986334 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39749279 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39594537 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39123306 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39021462 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37502408 |
| 139 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37321353 |
| 140 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37003726 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36670619 |
| 142 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36493220 |
| 143 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.34722708 |
| 144 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34648138 |
| 145 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33887658 |
| 146 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33485422 |
| 147 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33165181 |
| 148 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33114664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.35681907 |
| 2 | MP0005360_urolithiasis | 7.55664543 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47642279 |
| 4 | MP0005365_abnormal_bile_salt | 6.18729072 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19231281 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26299956 |
| 7 | MP0003252_abnormal_bile_duct | 3.92536427 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60056439 |
| 9 | MP0009840_abnormal_foam_cell | 3.32332309 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11388836 |
| 11 | MP0003195_calcinosis | 2.83130904 |
| 12 | MP0005332_abnormal_amino_acid | 2.74814755 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58936151 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.28607033 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16456014 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11987283 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10842416 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95311764 |
| 19 | MP0003868_abnormal_feces_composition | 1.94257330 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82544978 |
| 21 | MP0001764_abnormal_homeostasis | 1.67550310 |
| 22 | MP0009697_abnormal_copulation | 1.61696911 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56929398 |
| 24 | MP0005451_abnormal_body_composition | 1.48377287 |
| 25 | MP0003011_delayed_dark_adaptation | 1.38051428 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.27246967 |
| 27 | MP0003186_abnormal_redox_activity | 1.26031993 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.20759120 |
| 29 | MP0000598_abnormal_liver_morphology | 1.17579653 |
| 30 | MP0005647_abnormal_sex_gland | 1.14160666 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.13071256 |
| 32 | MP0005187_abnormal_penis_morphology | 1.12113447 |
| 33 | MP0000604_amyloidosis | 1.09220838 |
| 34 | MP0009764_decreased_sensitivity_to | 1.05367713 |
| 35 | MP0009763_increased_sensitivity_to | 1.02010123 |
| 36 | MP0002254_reproductive_system_inflammat | 1.00646768 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.96910220 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.88996346 |
| 39 | MP0001915_intracranial_hemorrhage | 0.88795502 |
| 40 | MP0008469_abnormal_protein_level | 0.88147898 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.86493345 |
| 42 | MP0005408_hypopigmentation | 0.85420401 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.81671012 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.79810441 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 0.78490327 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 0.77252401 |
| 47 | MP0005670_abnormal_white_adipose | 0.77076309 |
| 48 | MP0002876_abnormal_thyroid_physiology | 0.76339308 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.76003392 |
| 50 | MP0002971_abnormal_brown_adipose | 0.70773366 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.70034509 |
| 52 | MP0003690_abnormal_glial_cell | 0.69048630 |
| 53 | MP0005334_abnormal_fat_pad | 0.69031295 |
| 54 | MP0004130_abnormal_muscle_cell | 0.68784184 |
| 55 | MP0005535_abnormal_body_temperature | 0.66939354 |
| 56 | MP0001661_extended_life_span | 0.65922119 |
| 57 | MP0009053_abnormal_anal_canal | 0.65559213 |
| 58 | MP0005266_abnormal_metabolism | 0.64692769 |
| 59 | MP0003329_amyloid_beta_deposits | 0.63537317 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.61216161 |
| 61 | MP0010386_abnormal_urinary_bladder | 0.60100670 |
| 62 | MP0001756_abnormal_urination | 0.57686781 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.55981888 |
| 64 | MP0005448_abnormal_energy_balance | 0.55369797 |
| 65 | MP0003879_abnormal_hair_cell | 0.54507174 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.53003888 |
| 67 | MP0002822_catalepsy | 0.52643801 |
| 68 | MP0005058_abnormal_lysosome_morphology | 0.51792935 |
| 69 | MP0005395_other_phenotype | 0.48492727 |
| 70 | MP0008874_decreased_physiological_sensi | 0.46584708 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.45933040 |
| 72 | MP0003718_maternal_effect | 0.45899816 |
| 73 | MP0002928_abnormal_bile_duct | 0.44721224 |
| 74 | MP0008873_increased_physiological_sensi | 0.44424741 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.43454333 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.43366805 |
| 77 | MP0002282_abnormal_trachea_morphology | 0.42063148 |
| 78 | MP0003436_decreased_susceptibility_to | 0.42016471 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.41810121 |
| 80 | MP0003724_increased_susceptibility_to | 0.41597498 |
| 81 | MP0003075_altered_response_to | 0.40910711 |
| 82 | MP0005248_abnormal_Harderian_gland | 0.40332190 |
| 83 | MP0003953_abnormal_hormone_level | 0.40085038 |
| 84 | MP0004381_abnormal_hair_follicle | 0.38973956 |
| 85 | MP0008872_abnormal_physiological_respon | 0.38873398 |
| 86 | MP0009672_abnormal_birth_weight | 0.37703454 |
| 87 | MP0005166_decreased_susceptibility_to | 0.37232829 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.35344526 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.35234374 |
| 90 | MP0004883_abnormal_blood_vessel | 0.32997889 |
| 91 | MP0006082_CNS_inflammation | 0.32758904 |
| 92 | MP0000579_abnormal_nail_morphology | 0.32702725 |
| 93 | MP0000249_abnormal_blood_vessel | 0.32648798 |
| 94 | MP0001243_abnormal_dermal_layer | 0.32444086 |
| 95 | MP0009115_abnormal_fat_cell | 0.32249305 |
| 96 | MP0002796_impaired_skin_barrier | 0.31930011 |
| 97 | MP0002168_other_aberrant_phenotype | 0.30917845 |
| 98 | MP0001853_heart_inflammation | 0.30782155 |
| 99 | MP0009785_altered_susceptibility_to | 0.30750088 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.30694994 |
| 101 | MP0003959_abnormal_lean_body | 0.30155437 |
| 102 | MP0002970_abnormal_white_adipose | 0.29560117 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.29310149 |
| 104 | MP0005023_abnormal_wound_healing | 0.29271063 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.27524775 |
| 106 | MP0001881_abnormal_mammary_gland | 0.26957466 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.26930764 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.25442782 |
| 109 | MP0002090_abnormal_vision | 0.25346334 |
| 110 | MP0002132_abnormal_respiratory_system | 0.24943839 |
| 111 | MP0005164_abnormal_response_to | 0.24818256 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.23091124 |
| 113 | MP0002060_abnormal_skin_morphology | 0.23071899 |
| 114 | MP0004142_abnormal_muscle_tone | 0.22433566 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.18557846 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.17914524 |
| 117 | MP0003632_abnormal_nervous_system | 0.17587339 |
| 118 | MP0002249_abnormal_larynx_morphology | 0.15316191 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.14918465 |
| 120 | MP0003631_nervous_system_phenotype | 0.14304702 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.14049042 |
| 122 | MP0000371_diluted_coat_color | 0.14027613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.50757363 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46008607 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34906406 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69891953 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.64908887 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46521535 |
| 7 | Xanthomatosis (HP:0000991) | 6.28876867 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.64819616 |
| 9 | Complement deficiency (HP:0004431) | 5.30383219 |
| 10 | Joint hemorrhage (HP:0005261) | 4.86069824 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.83801890 |
| 12 | Hyperammonemia (HP:0001987) | 4.61918714 |
| 13 | Epidermoid cyst (HP:0200040) | 4.47733673 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45740359 |
| 15 | Hyperglycinemia (HP:0002154) | 4.44522598 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42361796 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.32347413 |
| 18 | Ketosis (HP:0001946) | 4.27185050 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25278857 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.24394251 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13767810 |
| 22 | Fat malabsorption (HP:0002630) | 4.12189683 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09284778 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.90620033 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90620033 |
| 26 | Hyperglycinuria (HP:0003108) | 3.90103102 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87658303 |
| 28 | Abnormality of complement system (HP:0005339) | 3.86748312 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.84513516 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79376178 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74549821 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 3.74540038 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.64555315 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38892539 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.37824550 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35042879 |
| 37 | Osteomalacia (HP:0002749) | 3.18846988 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.14219730 |
| 39 | Steatorrhea (HP:0002570) | 3.12612567 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.08350435 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06557146 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.00213766 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 3.00133306 |
| 44 | Ketoacidosis (HP:0001993) | 2.99177418 |
| 45 | Spontaneous abortion (HP:0005268) | 2.97880583 |
| 46 | Myocardial infarction (HP:0001658) | 2.94791799 |
| 47 | Metabolic acidosis (HP:0001942) | 2.76591395 |
| 48 | Skin nodule (HP:0200036) | 2.75732165 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.70551827 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.66006567 |
| 51 | Pulmonary embolism (HP:0002204) | 2.64687887 |
| 52 | Lethargy (HP:0001254) | 2.60103851 |
| 53 | Vascular calcification (HP:0004934) | 2.59498046 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.59028936 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59028936 |
| 56 | Fair hair (HP:0002286) | 2.56098233 |
| 57 | Acanthocytosis (HP:0001927) | 2.53519491 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.49622483 |
| 59 | Spastic diplegia (HP:0001264) | 2.46087815 |
| 60 | Glomerulonephritis (HP:0000099) | 2.45047218 |
| 61 | Arthropathy (HP:0003040) | 2.44885332 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.44440619 |
| 63 | Cholelithiasis (HP:0001081) | 2.42811588 |
| 64 | Mitral stenosis (HP:0001718) | 2.42623012 |
| 65 | Cerebral edema (HP:0002181) | 2.41353207 |
| 66 | Gout (HP:0001997) | 2.40235300 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.37651065 |
| 68 | Cholecystitis (HP:0001082) | 2.37651065 |
| 69 | Neonatal hypoglycemia (HP:0001998) | 2.36531488 |
| 70 | Irritability (HP:0000737) | 2.35087408 |
| 71 | Neonatal onset (HP:0003623) | 2.34146226 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.34102552 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33777118 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.30232545 |
| 75 | Amyloidosis (HP:0011034) | 2.29950717 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.29631746 |
| 77 | Glycosuria (HP:0003076) | 2.29631746 |
| 78 | Malnutrition (HP:0004395) | 2.25153609 |
| 79 | Purpura (HP:0000979) | 2.21731626 |
| 80 | Gingival bleeding (HP:0000225) | 2.20977686 |
| 81 | Abnormal biliary tract physiology (HP:0012439) | 2.19598247 |
| 82 | Bile duct proliferation (HP:0001408) | 2.19598247 |
| 83 | Esophageal varix (HP:0002040) | 2.19014687 |
| 84 | Menorrhagia (HP:0000132) | 2.18513718 |
| 85 | Pancreatitis (HP:0001733) | 2.13921776 |
| 86 | Brushfield spots (HP:0001088) | 2.13582003 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.12993989 |
| 88 | Elevated alkaline phosphatase (HP:0003155) | 2.11057652 |
| 89 | Enlarged kidneys (HP:0000105) | 2.09687190 |
| 90 | Late onset (HP:0003584) | 2.09232385 |
| 91 | Thrombophlebitis (HP:0004418) | 2.07704593 |
| 92 | Vomiting (HP:0002013) | 2.05939091 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.04342864 |
| 94 | Opisthotonus (HP:0002179) | 2.03231076 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.03225309 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 2.02300213 |
| 97 | Poikilocytosis (HP:0004447) | 2.02229166 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.01085666 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97828385 |
| 100 | Rickets (HP:0002748) | 1.93027680 |
| 101 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.92117069 |
| 102 | Increased serum ferritin (HP:0003281) | 1.90573286 |
| 103 | Renal cortical cysts (HP:0000803) | 1.87893644 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.87308402 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.87285249 |
| 106 | Gangrene (HP:0100758) | 1.86333462 |
| 107 | Abnormal urine phosphate concentration (HP:0012599) | 1.85960810 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.85930664 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84236268 |
| 110 | Atrioventricular block (HP:0001678) | 1.83269130 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.81532786 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.81532786 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.81119332 |
| 114 | Status epilepticus (HP:0002133) | 1.81097317 |
| 115 | Retinal atrophy (HP:0001105) | 1.80579950 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80398211 |
| 117 | Alkalosis (HP:0001948) | 1.78865683 |
| 118 | Generalized hypopigmentation of hair (HP:0011358) | 1.77820376 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.74328958 |
| 120 | Nephritis (HP:0000123) | 1.73782317 |
| 121 | Hyperglycemia (HP:0003074) | 1.72657881 |
| 122 | Proximal tubulopathy (HP:0000114) | 1.71209413 |
| 123 | Epistaxis (HP:0000421) | 1.61185239 |
| 124 | Abnormal pupillary function (HP:0007686) | 1.56366688 |
| 125 | Joint swelling (HP:0001386) | 1.52973767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24832682 |
| 2 | SIK1 | 4.64118288 |
| 3 | FGFR4 | 4.61214114 |
| 4 | ERN1 | 4.31984634 |
| 5 | MUSK | 3.36638511 |
| 6 | TAOK3 | 3.12692174 |
| 7 | INSRR | 2.96406762 |
| 8 | ERBB4 | 2.80986014 |
| 9 | MAP2K4 | 2.36896607 |
| 10 | PKN2 | 2.35313785 |
| 11 | PDK2 | 2.28461627 |
| 12 | ACVR1B | 2.22156355 |
| 13 | MAP3K12 | 2.10707273 |
| 14 | MST1R | 2.07520987 |
| 15 | FLT3 | 2.01184515 |
| 16 | PIK3CG | 1.86156284 |
| 17 | MAPK11 | 1.83217164 |
| 18 | BLK | 1.77566565 |
| 19 | CDK12 | 1.74716317 |
| 20 | TRIB3 | 1.73087776 |
| 21 | TYK2 | 1.71894156 |
| 22 | LATS1 | 1.63328878 |
| 23 | DAPK2 | 1.51352766 |
| 24 | ABL2 | 1.50500849 |
| 25 | PTK6 | 1.43835267 |
| 26 | FGFR2 | 1.41406979 |
| 27 | NEK9 | 1.36940026 |
| 28 | AKT3 | 1.35365625 |
| 29 | KDR | 1.34125297 |
| 30 | FRK | 1.32335069 |
| 31 | NTRK3 | 1.31062162 |
| 32 | MYLK | 1.26638365 |
| 33 | JAK2 | 1.22049217 |
| 34 | TESK2 | 1.20268714 |
| 35 | MAP3K7 | 1.19294935 |
| 36 | BRD4 | 1.16703043 |
| 37 | PINK1 | 1.16283032 |
| 38 | PRKAA2 | 1.12771117 |
| 39 | WNK3 | 1.09805106 |
| 40 | MAP2K3 | 1.08055613 |
| 41 | GRK6 | 1.07951262 |
| 42 | TBK1 | 1.05287535 |
| 43 | MAP3K14 | 1.01912224 |
| 44 | JAK1 | 1.01366779 |
| 45 | ERBB2 | 0.99722195 |
| 46 | MAPK4 | 0.99125196 |
| 47 | MAP3K10 | 0.97442980 |
| 48 | EIF2AK3 | 0.97428883 |
| 49 | CAMKK2 | 0.97415642 |
| 50 | MAP3K2 | 0.97089955 |
| 51 | PRKG1 | 0.93170356 |
| 52 | PRKCZ | 0.92869022 |
| 53 | NLK | 0.92544864 |
| 54 | CSNK1D | 0.87962807 |
| 55 | MET | 0.86719942 |
| 56 | EPHB1 | 0.86698446 |
| 57 | STK38L | 0.84705120 |
| 58 | PRKACA | 0.83140518 |
| 59 | TNK2 | 0.83105276 |
| 60 | CDK6 | 0.81780609 |
| 61 | MAPK12 | 0.81419688 |
| 62 | MAPK15 | 0.81195889 |
| 63 | MAP3K3 | 0.80929471 |
| 64 | TIE1 | 0.80541285 |
| 65 | MAP3K11 | 0.78232101 |
| 66 | SGK1 | 0.77849161 |
| 67 | PRKACG | 0.76357103 |
| 68 | EPHA3 | 0.75384844 |
| 69 | CSK | 0.74414864 |
| 70 | CAMK1D | 0.72683887 |
| 71 | FER | 0.71220302 |
| 72 | ARAF | 0.69312258 |
| 73 | DYRK1B | 0.68913605 |
| 74 | CAMK2G | 0.68756168 |
| 75 | MAP2K6 | 0.68126116 |
| 76 | STK38 | 0.67943924 |
| 77 | GSK3A | 0.66814541 |
| 78 | PRKAA1 | 0.64949137 |
| 79 | PRKCB | 0.64616948 |
| 80 | IRAK3 | 0.64456463 |
| 81 | CASK | 0.64396055 |
| 82 | MAP3K9 | 0.63726993 |
| 83 | PRKCE | 0.63026432 |
| 84 | SGK3 | 0.62336681 |
| 85 | CSF1R | 0.62242483 |
| 86 | TGFBR2 | 0.59741054 |
| 87 | MAPK7 | 0.59735619 |
| 88 | STK16 | 0.59157553 |
| 89 | PRKACB | 0.57819224 |
| 90 | FGFR3 | 0.56616505 |
| 91 | IKBKE | 0.55067695 |
| 92 | RIPK1 | 0.54991870 |
| 93 | PTK2 | 0.54254669 |
| 94 | PRKCQ | 0.53384520 |
| 95 | PDPK1 | 0.50943371 |
| 96 | EPHA4 | 0.50772816 |
| 97 | CSNK1G1 | 0.49721802 |
| 98 | RPS6KA3 | 0.49511514 |
| 99 | TAOK2 | 0.46511918 |
| 100 | GRK1 | 0.45696662 |
| 101 | SGK2 | 0.45147699 |
| 102 | IGF1R | 0.44832737 |
| 103 | MAP3K13 | 0.44250979 |
| 104 | RET | 0.44197275 |
| 105 | PRPF4B | 0.43330233 |
| 106 | PBK | 0.42746767 |
| 107 | MAP3K5 | 0.42349128 |
| 108 | BMPR1B | 0.42052740 |
| 109 | DYRK1A | 0.41982385 |
| 110 | CDK4 | 0.41512625 |
| 111 | PRKCG | 0.40684995 |
| 112 | CSNK1A1 | 0.40595782 |
| 113 | MAP2K1 | 0.39171431 |
| 114 | PKN1 | 0.38351713 |
| 115 | ICK | 0.37763768 |
| 116 | MAP3K6 | 0.37191523 |
| 117 | CDK9 | 0.35955862 |
| 118 | MTOR | 0.34938602 |
| 119 | KSR2 | 0.34281640 |
| 120 | MAP4K2 | 0.34130769 |
| 121 | EGFR | 0.33744769 |
| 122 | IKBKB | 0.33586943 |
| 123 | PDK1 | 0.32536270 |
| 124 | CAMK4 | 0.32275023 |
| 125 | CAMKK1 | 0.30998367 |
| 126 | SGK494 | 0.30915323 |
| 127 | SGK223 | 0.30915323 |
| 128 | CSNK1G2 | 0.29533331 |
| 129 | RAF1 | 0.29149454 |
| 130 | CHUK | 0.28666966 |
| 131 | MAP3K1 | 0.27449297 |
| 132 | IRAK2 | 0.27375594 |
| 133 | CSNK1G3 | 0.26597447 |
| 134 | LATS2 | 0.26591121 |
| 135 | CAMK1G | 0.26521629 |
| 136 | PRKCA | 0.25833499 |
| 137 | IRAK1 | 0.25464072 |
| 138 | PIK3CA | 0.24223211 |
| 139 | ABL1 | 0.21717814 |
| 140 | PAK3 | 0.21273219 |
| 141 | PDK4 | 0.20578342 |
| 142 | PDK3 | 0.20578342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54760275 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55335142 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39542498 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37302491 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05493889 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75836100 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74164978 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69016027 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63544330 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53071718 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48643912 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38364116 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27763697 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16599944 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16151897 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07466748 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97424134 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96967065 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95583873 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93298682 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91286098 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86736581 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81914468 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79609487 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76340887 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76217206 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73405501 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73104755 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71595755 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67202183 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63540317 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56789570 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56080413 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50307325 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48736130 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44242853 |
| 37 | * Bile secretion_Homo sapiens_hsa04976 | 1.40237051 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37153525 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35454588 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34339417 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30240218 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28748927 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22019879 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20177302 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19869814 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18837670 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15548540 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11570931 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02096194 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99424311 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98967821 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97557718 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96148228 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93951843 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92923773 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86143805 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84446565 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82140374 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81452028 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75973347 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69578986 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67395295 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63059039 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56149758 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54451113 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45679830 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45506060 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39232427 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.34979099 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25335852 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24702231 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23170559 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.22839506 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22300329 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21438268 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20959935 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.19614811 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15539875 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09747240 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09499741 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.04782080 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.03261160 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01742339 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2449336 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2420601 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2415716 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2407820 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2360392 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2257630 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2220252 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2067881 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1989264 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1971781 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1945025 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1853588 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1822929 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1654247 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1638430 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1609957 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1599645 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1466350 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1359583 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1310927 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1048726 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0856459 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0850713 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0639746 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0537392 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0428612 |

